BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 1424051)

  • 21. The three processes leading to post PTCA restenosis: dependence on the lesion substrate.
    Fuster V; Falk E; Fallon JT; Badimon L; Chesebro JH; Badimon JJ
    Thromb Haemost; 1995 Jul; 74(1):552-9. PubMed ID: 8578523
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical-pathological correlations of coronary disease progression and regression.
    Fuster V; Badimon JJ; Badimon L
    Circulation; 1992 Dec; 86(6 Suppl):III1-11. PubMed ID: 1424042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LEW-to-F344 carotid artery allografts: analysis of a rat model of posttransplant vascular injury involving cell-mediated and humoral responses.
    Hancock WW; Shi C; Picard MH; Bianchi C; Russell ME
    Transplantation; 1995 Dec; 60(12):1565-72. PubMed ID: 8545891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of neointimal thickening by a newly developed HMG-CoA reductase inhibitor, BAYw6228, and its inhibitory effect on vascular smooth muscle cell growth.
    Igarashi M; Takeda Y; Mori S; Ishibashi N; Komatsu E; Takahashi K; Fuse T; Yamamura M; Kubo K; Sugiyama Y; Saito Y
    Br J Pharmacol; 1997 Mar; 120(6):1172-8. PubMed ID: 9134232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of vascular smooth muscle cell proliferation and arterial intimal thickening by a novel antiproliferative naphthopyran.
    Wiernicki TR; Bean JS; Dell C; Williams A; Wood D; Kauffman RF; Singh JP
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1452-9. PubMed ID: 8819533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutated p21/WAF/CIP transgene overexpression reduces smooth muscle cell proliferation, macrophage deposition, oxidation-sensitive mechanisms, and restenosis in hypercholesterolemic apolipoprotein E knockout mice.
    Condorelli G; Aycock JK; Frati G; Napoli C
    FASEB J; 2001 Oct; 15(12):2162-70. PubMed ID: 11641242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coronary atherosclerosis. A multifactorial disease.
    Badimon JJ; Fuster V; Chesebro JH; Badimon L
    Circulation; 1993 Mar; 87(3 Suppl):II3-16. PubMed ID: 8443920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Platelet-derived growth factor and mechanism of cell proliferation of arterial smooth muscle: macrophage-derived growth factor and arteriosclerosis].
    Shimokado K; Tsukada T; Numano F
    Nihon Rinsho; 1988 Mar; 46(3):600-7. PubMed ID: 2457120
    [No Abstract]   [Full Text] [Related]  

  • 29. Molecular biology: insight into the causes and prevention of restenosis after arterial intervention.
    Wilcox JN
    Am J Cardiol; 1993 Oct; 72(13):88E-95E. PubMed ID: 8213576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF.
    Ferns GA; Raines EW; Sprugel KH; Motani AS; Reidy MA; Ross R
    Science; 1991 Sep; 253(5024):1129-32. PubMed ID: 1653454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty.
    Harker LA
    Am J Cardiol; 1987 Jul; 60(3):20B-28B. PubMed ID: 2956836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue characteristics of restenosis after percutaneous transluminal coronary angioplasty in diabetic patients.
    Moreno PR; Fallon JT; Murcia AM; Leon MN; Simosa H; Fuster V; Palacios IF
    J Am Coll Cardiol; 1999 Oct; 34(4):1045-9. PubMed ID: 10520788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of cytokines in the pathogenesis of restenosis after percutaneous transluminal coronary angioplasty.
    Tashiro H; Shimokawa H; Sadamatsu K; Aoki T; Yamamoto K
    Coron Artery Dis; 2001 Mar; 12(2):107-13. PubMed ID: 11281299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Vascular smooth muscle cells in coronary heart disease].
    Tsukamoto T; Matsui T
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):100-4. PubMed ID: 12436513
    [No Abstract]   [Full Text] [Related]  

  • 35. Coronary angioplasty from the perspective of atherosclerotic plaque: morphologic predictors of immediate success and restenosis.
    Virmani R; Farb A; Burke AP
    Am Heart J; 1994 Jan; 127(1):163-79. PubMed ID: 8273736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia.
    Liu MW; Roubin GS; King SB
    Circulation; 1989 Jun; 79(6):1374-87. PubMed ID: 2524293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of neointima formation--lessons from experimental models.
    De Meyer GR; Bult H
    Vasc Med; 1997; 2(3):179-89. PubMed ID: 9546967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human atherosclerosis. IV. Immunocytochemical analysis of cell activation and proliferation in lesions of young adults.
    Katsuda S; Coltrera MD; Ross R; Gown AM
    Am J Pathol; 1993 Jun; 142(6):1787-93. PubMed ID: 8099470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammatory cytokines stimulate vascular smooth muscle cells locomotion and growth by enhancing alpha5beta1 integrin expression and function.
    Barillari G; Albonici L; Incerpi S; Bogetto L; Pistritto G; Volpi A; Ensoli B; Manzari V
    Atherosclerosis; 2001 Feb; 154(2):377-85. PubMed ID: 11166770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The smooth muscle cell: sinner or saint in restenosis and the acute coronary syndromes?
    Lafont A; Libby P
    J Am Coll Cardiol; 1998 Jul; 32(1):283-5. PubMed ID: 9669282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.